Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
658.6 INR | -1.43% | -0.24% | +99.39% |
Jul. 10 | Shilpa Medicare Arm's API Facility in Karnataka, India, Passes Brazilian Drug Regulator's Inspection | MT |
Jul. 09 | Shilpa Medicare to Receive Shares from Unit as Loan Payment | MT |
Sales 2022 | 11.47B 137M | Sales 2023 | 10.52B 126M | Capitalization | 19.91B 238M |
---|---|---|---|---|---|
Net income 2022 | 607M 7.27M | Net income 2023 | -325M -3.89M | EV / Sales 2022 | 3.58 x |
Net Debt 2022 | 6.58B 78.77M | Net Debt 2023 | 7.79B 93.27M | EV / Sales 2023 | 2.63 x |
P/E ratio 2022 |
54.7
x | P/E ratio 2023 |
-61.3
x | Employees | 1,179 |
Yield 2022 |
0.28% | Yield 2023 |
-
| Free-Float | 40.56% |
Latest transcript on Shilpa Medicare Limited
1 day | -1.43% | ||
1 week | -0.24% | ||
Current month | +15.62% | ||
1 month | +22.47% | ||
3 months | +30.22% | ||
6 months | +99.76% | ||
Current year | +99.39% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 87-11-19 | |
Alpesh Dalal
DFI | Director of Finance/CFO | - | 21-05-30 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 87-11-19 | |
Director/Board Member | 59 | 21-09-01 | |
Arvind Vasudeva
BRD | Director/Board Member | 63 | 21-09-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-12 | 658.6 | -1.43% | 179,183 |
24-07-11 | 668.2 | +2.71% | 268,769 |
24-07-10 | 650.6 | -1.32% | 397,343 |
24-07-09 | 659.2 | -1.19% | 312,274 |
24-07-08 | 667.2 | +1.06% | 754,894 |
Delayed Quote NSE India S.E., July 12, 2024 at 07:43 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- SHILPAMED Stock
- SHILPAMED Stock